Lopinavir Recruiting Phase 4 Trials for Infections, Coronavirus Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04252885The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection